marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Iterum Therapeutics Financial Ratios 2011-2024 | ITRM
Annual Financial Ratios Iterum Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.5 | -0.3 | -0.0 | -0.0 | -0.4 | -1.3 | - | - | - | - | - | - | - |
P/S |
- | - | - | - | 984.9 | 111.3 | - | - | - | - | - | - | - |
EPS |
-3.0 | -3.6 | -8.4 | -32.5 | -7.1 | -8.8 | -170.8 | -568.9 | - | - | - | - | - |
EV (Enterprise Value) |
46.6 M | 31.6 M | 17.6 M | 71.1 M | 83.6 M | 78.4 M | 7.26 M | 4.25 M | - | - | - | - | - |
EBITDA per Share |
-3.66 | -2.48 | -2.22 | -20 | -7.02 | -5.32 | - | - | - | - | - | - | - |
EV/EBITDA |
-0.6 | -1.6 | -0.4 | -0.9 | - | - | - | - | - | - | - | ||
PEG |
- | 0.01 | -0.01 | -0.18 | - | - | - | - | - | - | - | ||
P/B |
-3.1 | 0.5 | 0.1 | -0.0 | -1.4 | 1.4 | - | - | - | - | - | - | - |
P/CF |
-0.5 | -0.7 | -0.2 | -0.0 | -0.5 | -1.3 | - | - | - | - | - | - | - |
ROE % |
599.27 | -158.70 | -182.27 | 102.86 | 393.06 | -107.59 | - | - | - | - | - | - | - |
ROA % |
-146.13 | -66.49 | -100.06 | -158.59 | -400.49 | -78.73 | - | - | - | - | - | - | - |
ROCE % |
741.34 | -108.51 | -48.85 | 63.54 | 908.06 | -89.38 | - | - | - | - | - | - | - |
Current Ratio |
0.8 | 1.7 | 2.2 | 0.4 | 0.3 | 7.6 | - | - | - | - | - | - | - |
DSO |
- | - | - | - | 739.9 | 133.1 | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Iterum Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.3 | -0.3 | -0.46 | -0.3 | -0.95 | -0.78 | - | -2.38 | -0.55 | -0.29 | - | 0.31 | 0.04 | -0.81 | -0.28 | -0.6 | -0.8 | -1.08 | -1.59 | -2.15 | -1.93 | -1.44 | -1.72 | -1.77 | -2.22 | -61.36 | - | -44.16 | -39.44 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.4 | - | - | -0.67 | - | -0.57 | -0.65 | -0.6 | - | -0.37 | -0.04 | -0.05 | - | -0.3 | -0.52 | -0.86 | - | -2.12 | -1.9 | -1.42 | - | -1.77 | -2.16 | -61 | - | -44.5 | -39.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
101.25 | -123.45 | -221.40 | -426.30 | -402.76 | -246.37 | -111.97 | -104.84 | -8.28 | 23.59 | -290.21 | -312.33 | -216.61 | -130.27 | 286.46 | 398.69 | 688.88 | 979.08 | 1269.27 | 1145.30 | 644.66 | 144.01 | -356.63 | -397.22 | -364.09 | -330.96 | -148.91 | -148.91 | -74.46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-119.47 | -105.19 | -86.95 | -91.45 | -122.37 | -107.16 | -53.63 | -49.83 | -5.34 | 10.79 | -74.74 | -108.85 | -271.25 | -437.19 | -509.89 | -567.59 | -809.48 | -1051.38 | -1293.27 | -1226.25 | -904.50 | -582.74 | -260.98 | -299.09 | -283.25 | -267.41 | -125.78 | -125.78 | -62.89 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-307.04 | -501.32 | -582.75 | -704.57 | -240.02 | -106.56 | -55.11 | -64.41 | -52.09 | -48.55 | -42.65 | -30.12 | -8.30 | 22.83 | 54.36 | 172.50 | 278.12 | 366.14 | 300.49 | 265.61 | 112.57 | -13.31 | -73.46 | -94.47 | -80.59 | -75.29 | -37.24 | -37.24 | -16.24 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.6 | 0.6 | 0.8 | 1.1 | 1.2 | 1.5 | 1.7 | 1.8 | 2.3 | 2.4 | 2.2 | 2.1 | 1.8 | 1.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 3.7 | 3.7 | 3.7 | 3.7 | 6.5 | 6.5 | 6.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency